Page results
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
RNOH are pleased to launch a series of regular Health and Wellbeing Information and Support Sessions to support patients following a cancer diagnosis and also during/after treatment. These…
-
All medications given to you while you are an inpatient are provided free of charge. At follow-up appointments, you may be given a prescription by your doctor or nurse. This must be collected from the hospital pharmacy; you cannot take it to your local chemist. There is a standard prescription charge per item which you can pay for by cash or card.
-
The UCLH@Home service is helping patients like 55-year-old Sherena Kranat to continue their recovery in their own home under the care of their hospital team.
-
Pioneering neurologist who worked at NHNN is commemorated with an English Heritage London blue plaque at his Wimpole Street home where he had his private practice.
-
Our clinical neurophysiology department performs tests which record information from the brain or the nervous system. There are two main tests performed in our outpatient department, Electroencephalogram (EEG) and Nerve conduction studies (NCS).
-
In the UK in 2020, 23 million Novo Nordisk FlexPen and FlexTouch pre-filled devices were incinerated or sent to landfill as there was no viable recycling alternative.
-
Here is an invitation to the Medtronic diabetes patient education web events.
File results
-
FOI/2024/0704 - Contingencies to support visitors/ patients/ contractors witnessing a distressing event
-
FOI/2024/0709 - Number of dilation and curettage operations for miscarriages 2019-2024
-
FOI/2024/0712 - Occupational health services, spend/ in-house/ outsourced 2021/22-2023/24
-
FOI/2024/0716 - Toxicological screening/ testing/ training and information to patients
-
FOI/2024/0718 - Mental health/ electronic health records software/ dermatology screening/ imaging services/ medical devices for wound care
-
FOI/2024/0719 - Tenders and prices for interpretation services
-
FOI/2024/0720 - Motion picture licensing corporation
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology
-
FOI/2024/0734 - Treatment and management of patients with Lupus 2023
-
FOI/2024/0736 - Outpatient/ elective activity performed on 14th-16th June 2023